Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9136

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 0143-9136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mitomycin Structural Formula (Mitomycin For Injection Usp Novaplus 1)

Chemical structure of Mitomycin, showing its fused ring system with oxygen, nitrogen, and methyl groups as depicted in the image.*

FDA Label Image

Structural Formula (Mitomycin For Injection Usp Novaplus 2)

Mitomycin 20 mg lyophilized powder for injection vial with label showing the proprietary and generic name Mitomycin. The vial includes information on dosage form as injection, powder, lyophilized, for solution, and the labeler as Hikma Pharmaceuticals USA Inc. The vial features a white cap and blue labeling with black text.*

FDA Label Image

Nova 20 mg Vial (Mitomycin For Injection Usp Novaplus 3)

Label for Mitomycin for Injection, USP 20 mg per vial, lyophilized powder for intravenous solution by Hikma Pharmaceuticals USA Inc. It includes dosage instructions, warnings about intravenous administration to avoid tissue damage, and storage conditions. The label lists manufacturing by THYMOORGAN PHARMAZIE GmbH, Germany, and distribution by Hikma, Berkeley Heights, NJ.*

FDA Label Image

Novaplus 40 mg Vial (Mitomycin For Injection Usp Novaplus 4)

Mitomycin for Injection, USP 40 mg per vial label showing usage warnings and storage instructions. The label states the injection is for intravenous use and warns to avoid tissue damage. It includes detailed dosage and storage guidelines, manufacturer THYMOORGAN PHARMAZIE GmbH, distributor Hikma Pharmaceuticals USA Inc., and branding for Novaplus.*

FDA Label Image

Novaplus 20 mg Carton (Mitomycin For Injection Usp Novaplus 5)

Mitomycin for Injection, USP 20 mg per vial packaging label. The label shows the drug name, strength, route (intravenous), and warnings about administration. Manufactured by THYMOORGAN PHARMAZIE GmbH and distributed by Hikma Pharmaceuticals USA Inc. Additional details include instructions for preparation, storage conditions, and a barcode. The design features a blue and white color scheme with the Novaplus logo.*

FDA Label Image

Novaplus 40 mg Carton (Mitomycin For Injection Usp Novaplus 6)

Mitomycin 40 mg per vial packaging label for injection, USP, powder lyophilized for intravenous solution by Hikma Pharmaceuticals USA Inc. The label includes dosing instructions, warnings about intravenous administration to avoid tissue damage, manufacturing and distribution details, and storage conditions. The box design is primarily white with blue and yellow accents, featuring the product name, strength, and Novaplus logo.*

FDA Label Image

Representative Carton Serialization Image (Mitomycin For Injection Usp Novaplus 7)

Mitomycin injection powder label featuring a Data Matrix barcode, lot number ABCDE12345, expiration date format MMMYYYY, GTIN 00301234567896, and serial number 12345678901234. Label is consistent with packaging for intravenous lyophilized powder for solution by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.